RiboTask

Langeskov, Denmark Founded: 2006 • Age: 20 yrs
LNA-modified RNA oligonucleotides are developed for RNAi and microRNA research.

About RiboTask

RiboTask is a Healthcare company based in Langeskov (Denmark) founded in 2006 by Suzy Wengel and Jesper Wengel. LNA-modified RNA oligonucleotides are developed for RNAi and microRNA research. The company has 1 employees. Its chief executive, as recorded, is Suzy Wengel. RiboTask offers products and services including Nucleic Acid Synthesis, RNA Design Services, and Therapeutics Consulting. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Technology Platforms. Its legal entity is RIBOTASK ApS.

Company details

RiboTask was established in 2006 in Langeskov, Denmark, within the biotechnology sector. RNA oligonucleotides are supplied for research and development, including complex structures and customer-specific modifications. UNA- and LNA-modified variants form core products, alongside Superior-Probes designed for microRNA applications. Efforts are directed toward advancing new RNA technologies and related innovations.

  • Headquarters Langeskov, Denmark
  • Employees 1
  • Founders Suzy Wengel, Jesper Wengel
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website ribotask.com
  • Social Facebook
  • Legal Name Ribotask Aps
Key Metrics

Products & Services of RiboTask

RiboTask offers a comprehensive portfolio of products and services, including Nucleic Acid Synthesis, RNA Design Services, and Therapeutics Consulting.

Nucleic Acid Synthesis
Chemistry Services

Services for synthesizing nucleotides and modifications for research.

RNA Design Services
Design Platforms

Design solutions for antisense, siRNA, and miRNA technologies.

Therapeutics Consulting
Biotech Consulting

Consulting on RNA technologies for therapeutic applications.

Funding Insights of RiboTask

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of RiboTask with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2006Seed––
Valuation history

1 investors in total: 1 institutional.

Investors in RiboTask

RiboTask has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Science Ventures Denmark.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Deep tech spin-outs are developed from SDU research collaborations.
scienceventures.dkOdense, Denmark
Premium access

Investor details for RiboTask

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of RiboTask

2 people are tracked at RiboTask (2 in leadership); the tracked headcount is 1.

NameRoleGroup
Suzy Wengel
Co-Founder & CEOLeadership
Jesper Wengel
Co-Founder & ChairmanLeadership
Premium access

Complete people profiles for RiboTask

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of RiboTask

2 dated milestones of RiboTask, from founding to its latest funding, stage changes and deals.

  1. Founded RiboTask is founded.
  2. Funding First funding round.

Web traffic of RiboTask

Websites that share an audience with RiboTask (ribotask.com).

Similar websites

Websites whose visitors overlap most with RiboTask. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
superarray.com
100%
View details
santaris.com
99%
View details
sylentis.com
87%
3.9K#4,931,838View details
asuragen.com
82%
8.4K#2,708,489View details
alnylam.com
74%
77.8K#414,009View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for RiboTask

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about RiboTask

RiboTask was founded in 2006.

RiboTask is headquartered in Langeskov, Denmark.

Suzy Wengel is the CEO of RiboTask, as recorded in our data. They have also founded this company.

RiboTask has 1 employees.

RiboTask was established in 2006 in Langeskov, Denmark, within the biotechnology sector. RNA oligonucleotides are supplied for research and development, including complex structures and customer-specific modifications. UNA- and LNA-modified variants form core products, alongside Superior-Probes designed for microRNA applications. Efforts are directed toward advancing new RNA technologies and related innovations.

RiboTask offers Nucleic Acid Synthesis, RNA Design Services, and Therapeutics Consulting.

RiboTask has 1 investor. Key investors include Science Ventures Denmark.

RiboTask operates through Ribotask Aps.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available